Search Contact

We are dedicated to microbiome science, leading more than 20 clinical studies today, all focused on investigating the link between bacterial strains and human health.

We develop and manufacture ready to market probiotics and  active ingredients (patented strains) with specific therapeutic benefits. 

All our products are unique and patented, and follow WHO and IPA guidelines for probiotic strains, ensuring efficacy and safety.

We can offer you the formulations (capsules, sticks, drops, etc.) that fit better in your market and portfolio.

As a Business to Business (B2B) company, our products are licensed and distribute worldwide through local distribution partners. If you want to become one of our partners please contact us.

We will be happy to help you!

Discover AB-BIOTICS probiotics by clicking on the therapeutical area you are most interested in:

Gastrointestinal health
+ Info

Cardiometabolic health
+ Info

Pediatric Health
+ Info

Women's health
+ Info

Immune health
+ Info

Oral health
+ Info

Brain health
+ Info

What are probiotics?

The World Health Organization (WHO) , the Food and Agriculture Organization (FAO) together with the International Scientific Association for Probiotics and Prebiotics (ISAPP) describes probiotics as live microorganisms which when administered in adequate amounts confer a health benefit on the host1,2.

Therefore, probiotics must simultaneously meet two conditions:

  1. Have clinical proof of effectiveness at an explicit number of live bacteria, stated in colony-forming units (CFUs).
  2. Same determined dosage must be specified in the package labelling and verified to be effective at the end of its shelf life.


AB-Biotics owns a large collection of bacterial strains, collected from several places around the world, containing more than 550 different wild-type strains.

Its own bank of natural strains -the biggest private strain bank in Europe- allows AB-Biotics to develop one of the most innovative and patented probiotic pipeline in the world.


The current evidence proves the beneficial effects of probiotics are strain-specific. According to the World Gastroenterology Organisation (WGO) Practice Guidelines on Probiotics and Prebiotics, the potential probiotic health benefits can only be attributed to the strain or strains tested, and not to the species or the whole group of lactic acid bacteria or other probiotics.

AB-Biotics products are strains selected because of their specific biofunctionalities. Our product development methodology replicates that of a drug, guaranteeing a strong clinical background that proves the safety and efficacy of our products for the improvement of specific health conditions.

Click here if you want to know more about our current clinical trials.


  1. FAO-WHO, 2002. Guideline for the Evaluation of Probiotics in Food.
  2. ISAPP, 2017. Probiotics.


  1. Identify putative Mechanism of Action
  2. Screen for the strains with the best performance, compared to commercial controls
  3. Validate in vivo / clinically
  4. High-concentration (>1×109 cfu/dose) and high-quality (24 month stability) presentations